BRC Group Holdings, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
RILY$3.66-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months EndedSeptember 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities(1): | ||
| Net (loss) income | $(3,936) | $219,985 |
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization | 22,505 | 27,232 |
| Provision for losses on accounts receivable | 1,223 | 2,589 |
| Share-based compensation | 7,250 | 11,018 |
| Fair value and remeasurement adjustments ($(106) and $3,186 from related parties) | (7,628) | (8,621) |
| Non-cash interest and other (includes $— and $(268) from related parties) | 5,288 | 9,203 |
| Depreciation of rental merchandise | 9,174 | 9,898 |
| Net foreign currency losses (gains) | 18 | (470) |
| Loss (income) from equity investments | 4,073 | (34,244) |
| Dividends from equity investments | 273 | 189 |
| Impairment of equity investment | 14,552 | — |
| Deferred income taxes | 270 | 9,164 |
| Impairment of tradename | 5,200 | 1,500 |
| Loss (gain) on disposal of discontinued operations | 2,401 | (66,795) |
| Loss (gain) on sale or disposal of fixed assets and other | 154 | (1,298) |
| Gain on sale and deconsolidation of businesses | — | (86,213) |
| (Gain) loss on extinguishment of debt | (1,607) | 21,643 |
| Gain on senior note exchange | — | (67,208) |
| Change in operating assets and liabilities: | ||
| Amounts due to/from clearing brokers | 31,598 | (117,578) |
| Securities and other investments owned | 75,295 | (33,989) |
| Securities borrowed | (120,072) | (63,755) |
| Accounts receivable | (4,810) | 238 |
| Prepaid expenses and other assets ($— and $3,331 from related parties) | (1,538) | 9,528 |
| Accounts payable, accrued expenses and other liabilities | (28,810) | 1,409 |
| Amounts due to/from related parties and partners | — | (910) |
| Securities sold not yet purchased | (1,912) | 16,700 |
| Deferred revenue | (4,877) | (6,126) |
| Securities loaned | 119,804 | 60,979 |
| Net cash provided by (used in) operating activities | 123,888 | (85,932) |
| Cash flows from investing activities(1): | ||
|---|---|---|
| Purchases of loans receivable ($— and $75,853 from related parties) | (50,852) | (114,255) |
| Repayments of loans receivable ($1,855 and $90,556 by related parties) | 80,676 | 137,744 |
| Proceeds from sale of loans receivable ($— and $6,611 from related parties) | — | 10,415 |
| Proceeds from loan participations sold | — | 4,475 |
| Proceeds from sale of business, net of cash sold and other | — | 94,938 |
| Purchases of property, equipment, and intangible assets | (3,877) | (10,283) |
| Proceeds from sale of property, equipment, intangible assets, and other | — | 7,587 |
| Distributions from equity investments | 3,477 | 37,536 |
| Purchases of equity and other investments | — | (6,621) |
| Consolidation of VIE | — | 359 |
| Proceeds from sale of discontinued operations, net of $— and $3,344 cash sold | — | 114,032 |
| Net cash provided by investing activities | 29,424 | 275,927 |
| Cash flows from financing activities(1): | ||
| Proceeds from revolving lines of credit | 147,224 | 86,065 |
| Repayment of revolving lines of credit | (121,577) | (92,227) |
| Proceeds from note payable | — | 850 |
| Repayment of notes payable and other | (893) | (13,437) |
| Repayment of term loans | (8,500) | (314,253) |
| Proceeds from term loans | — | 235,550 |
| Redemption of senior notes, net | (232,731) | (145,302) |
| Repurchases and payments on senior notes | (13,122) | — |
| Payment of debt issuance and offering costs | (1,195) | (13,207) |
| Payment of contingent consideration | — | (1,424) |
| Payment of employment taxes on vesting of restricted stock | (2,831) | — |
| Distributions to noncontrolling interests | (1,358) | (3,604) |
| Net cash used in financing activities | (234,983) | (260,989) |
| Decrease in cash, cash equivalents and restricted cash(1) | (81,671) | (70,994) |
| Effect of foreign currency on cash, cash equivalents and restricted cash(1) | (1,883) | (183) |
| Net decrease in cash, cash equivalents and restricted cash(1) | (83,554) | (71,177) |
| Cash, cash equivalents and restricted cash from continuing operations, beginning of period | 229,277 | 248,651 |
| Cash, cash equivalents and restricted cash from discontinued operations, beginning of period | — | 8,025 |
| Cash, cash equivalents and restricted cash, beginning of period | 229,277 | 256,676 |
| Cash, cash equivalents and restricted cash from continuing operations, end of period | 145,723 | 185,499 |
| Cash, cash equivalents and restricted cash from discontinued operations, end of period | — | — |
| Cash, cash equivalents and restricted cash, end of period | $145,723 | $185,499 |
| Reconciliation of cash, cash equivalents and restricted cash to amounts reported in the condensed consolidated balance sheets: | ||
| Cash and cash equivalents | $144,072 | $184,225 |
| Restricted cash | 1,651 | 1,274 |
| Total cash, cash equivalents and restricted cash | $145,723 | $185,499 |
| Supplemental disclosure of cash flow information: | ||
| Interest paid | $56,289 | $75,961 |
| Taxes paid | 1,485 | 2,888 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
|---|---|---|
| Transfer of loans to held for sale from loans receivable at fair value | $— | $8,876 |
| Issuance of common stock in equity of subsidiary | — | 1,575 |
| Issuance of warrants for term loan | — | 7,860 |
| Recombination of derivative liability for term loan springing maturity with its debt host | 844 | — |
| Recognition of derivative liability for term loan mandatory prepayment | 190 | — |
| Recognition of derivative liability for term loan exit fee | — | 11,244 |
| Exchange of term loan exit fee for payment-in-kind amendment fee | 3,125 | — |
| Disposition of noncontrolling interests through sale and deconsolidation of businesses | — | 2,918 |
| Capital from noncontrolling interest upon initial consolidation of VIE | — | 12,494 |
| Reclassification of restricted stock units from liability to equity | 2,589 | — |
| Reclassification of restricted stock units from equity to liability | — | 2,138 |
| Issuance of common stock in connection with redemption of senior notes | 67,785 | — |
| Issuance of warrants for senior notes | — | 1,848 |
| Settlement of warrant liability upon cashless exercise | 9,400 | — |
| Exchange of preferred stock investment for loan receivable | 1,198 | — |
(1) Amounts presented contain results from both continuing and discontinued operations. Refer to Note 5 - Discontinued Operations and Assets Held for Sale for additional information regarding cash flow associated with the results of discontinued operations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.